SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008385
Filing Date
2017-11-07
Accepted
2017-11-07 16:10:22
Documents
67
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocul-20170930x10q.htm 10-Q 2226723
2 EX-31.1 ocul-20170930ex311eabf94.htm EX-31.1 14535
3 EX-31.2 ocul-20170930ex312b4f0d8.htm EX-31.2 10184
4 EX-32.1 ocul-20170930ex321a4c021.htm EX-32.1 7096
5 EX-32.2 ocul-20170930ex3227a8ce6.htm EX-32.2 6737
  Complete submission text file 0001558370-17-008385.txt   5885067

Data Files

Seq Description Document Type Size
6 EX-101.INS ocul-20170930.xml EX-101.INS 923429
7 EX-101.SCH ocul-20170930.xsd EX-101.SCH 43185
8 EX-101.CAL ocul-20170930_cal.xml EX-101.CAL 50776
9 EX-101.DEF ocul-20170930_def.xml EX-101.DEF 154243
10 EX-101.LAB ocul-20170930_lab.xml EX-101.LAB 348997
11 EX-101.PRE ocul-20170930_pre.xml EX-101.PRE 287707
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36554 | Film No.: 171183476
SIC: 2834 Pharmaceutical Preparations